|
GXYLT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.522600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.774500E-04 |
| Normal-vs-Stage2 |
1.547650E-01 |
| Normal-vs-Stage3 |
2.071600E-01 |
| Normal-vs-Stage4 |
3.940800E-01 |
| Stage1-vs-Stage2 |
8.521200E-01 |
| Stage1-vs-Stage3 |
3.142000E-01 |
| Stage1-vs-Stage4 |
4.346500E-02 |
| Stage2-vs-Stage3 |
6.478600E-01 |
| Stage2-vs-Stage4 |
3.636800E-01 |
| Stage3-vs-Stage4 |
5.783600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.062100E-03 |
| Normal-vs-AfricanAmerican |
8.232800E-01 |
| Normal-vs-Asian |
2.627400E-01 |
| Caucasian-vs-AfricanAmerican |
3.955600E-03 |
| Caucasian-vs-Asian |
9.847000E-01 |
| AfricanAmerican-vs-Asian |
2.403200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.629700E-02 |
| Normal-vs-Female |
6.180300E-04 |
| Male-vs-Female |
6.341700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.916400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.082390E-02 |
| Normal-vs-Age(61-80Yrs) |
8.359700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.611800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.249640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.040590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.952000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.537400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.251000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.340600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.405690E-04 |
| Normal-vs-Grade 2 |
3.167900E-04 |
| Normal-vs-Grade 3 |
2.179800E-01 |
| Normal-vs-Grade 4 |
7.632600E-01 |
| Grade 1-vs-Grade 2 |
2.812000E-01 |
| Grade 1-vs-Grade 3 |
1.902520E-03 |
| Grade 1-vs-Grade 4 |
1.631110E-04 |
| Grade 2-vs-Grade 3 |
4.015100E-03 |
| Grade 2-vs-Grade 4 |
1.435050E-04 |
| Grade 3-vs-Grade 4 |
1.161020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.51480000001969E-06 |
| Normal-vs-ccB subtype |
1.884240E-01 |
| ccA subtype-vs-ccB subtype |
3.655600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.180800E-03 |
| Normal-vs-N1 |
6.125200E-01 |
| N0-vs-N1 |
4.803200E-01 |
|
|
